Documents in the NTIS Technical Reports collection are the results of federally funded research. They are directly submitted to or collected by NTIS from Federal agencies for permanent accessibility to industry, academia and the public.  Before purchasing from NTIS, you may want to check for free access from (1) the issuing organization's website; (2) the U.S. Government Printing Office's Federal Digital System website; (3) the federal government Internet portal; or (4) a web search conducted using a commercial search engine such as
Accession Number ADA564531
Title Intracellular Protein Delivery for Treating Breast Cancer.
Publication Date Jun 2012
Media Count 18p
Personal Author Y. Tang
Abstract The development of stimuli-responsive, nano-scale therapeutics that can selectively target tumors is a major research focus in cancer nanotechnology. A potent therapeutic option is directly arming the cancer cells with apoptotic-inducing proteins that are not targeted by anti-apoptotic maneuvers found in tumors. The avian virus derived apoptin forms a high molecular weight protein complex that selectively accumulates in the nuclei of cancer cells to induce apoptotic cell death. To enable the efficient delivery of this tumor-selective complex in functional form, we synthesized degradable, sub-100 nm, core-shell protein nanocapsules containing the 2.4 MDa apoptin complexes. Recombinant apoptin is reversibly encapsulated in a positively charged, water soluble polymeric shell and is released in native forms in response to reducing conditions such as the cytoplasm. The nanocapsules are efficiently internalized by mammalian cells lines as characterized by confocal microscopy, and rhodamine-labeled apoptin can be observed in the nuclei of cancer cells only. Released apoptin induced tumor-specific apoptosis in several cell lines and inhibited tumor growth in vivo, demonstrating the potential of this polymer-protein combination as a cancer therapeutic.
Keywords Apoptosis
Breast cancer
In vivo analysis
Molecular weight

Source Agency Non Paid ADAS
NTIS Subject Category 57E - Clinical Medicine
Corporate Author California Univ., Los Angeles.
Document Type Technical report
Title Note Annual rept. 15 May 2011-14 May 2012.
NTIS Issue Number 1303
Contract Number W81XWH-11-1-0371

Science and Technology Highlights

See a sampling of the latest scientific, technical and engineering information from NTIS in the NTIS Technical Reports Newsletter

Acrobat Reader Mobile    Acrobat Reader